Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma Sodium: a Predictor of Perforation in Acute Appendicitis. (The NAP-study)

NCT04806789 is registered in ClinicalTrials.gov with Urban Fläring as lead sponsor.

NCT NCT04806789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04806789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma Sodium: a Predictor of Perforation in Acute Appendicitis. (The NAP-study)
Lead sponsor
Urban Fläring
Phase
Observational
Overall status
Completed
Start date
June 1, 2021
Completion date
November 25, 2024
Enrollment
451 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute appendicitis, children, only